St Mark's Hospital, London, UK.
Colorectal Dis. 2020 Sep;22(9):1002-1005. doi: 10.1111/codi.15247. Epub 2020 Aug 17.
This report summarizes the early experience of implementing elective colorectal cancer surgery during the COVID-19 pandemic.
A pathway to minimize the risk of including COVID-19-positive patients for elective surgery was established. Prioritization and additional safety measures were introduced into clinical practice. Minimal invasive surgery was used where appropriate.
Thirty-eight patients were prioritized, and 23 patients underwent surgery (eight colon, 14 rectal and one anal cancer). The minimal invasive surgery rate was 78%. There were no major postoperative complications or patients diagnosed with COVID-19. Histopathological outcomes were similar to normal practice.
A safe pathway to offer standard high-quality surgery to colorectal cancer patients during the COVID-19 pandemic is feasible.
本报告总结了在 COVID-19 大流行期间实施择期结直肠癌手术的早期经验。
建立了一条将 COVID-19 阳性患者纳入择期手术风险最小化的途径。在临床实践中引入了优先级排序和额外的安全措施。在适当的情况下使用微创手术。
优先考虑了 38 名患者，其中 23 名患者接受了手术（8 例结肠癌，14 例直肠癌和 1 例肛门癌）。微创手术率为 78%。没有发生重大术后并发症或诊断为 COVID-19 的患者。组织病理学结果与常规实践相似。
在 COVID-19 大流行期间为结直肠癌患者提供标准高质量手术的安全途径是可行的。
